Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.
Non-Pharmacological Therapies may Provide Alternative Treatment Options in Fibromyalgia
September 29th 2022The 3-stage Delphi exercise used the expertise of medical and health care professionals with experience in treating patients with fibromyalgia. Treatment recommendations included exercise, education, cognitive behavioral therapy, mindfulness, and mind-body exercises.
Read More
Survey Addresses Concerns Regarding Reproductive Healthcare Communication in Women with RA, PsA
September 29th 2022Although the proportion of women treated with biologics continues to grow, data on treatment recommendations among both physicians and female patients of childbearing age remain limited.
Read More
Mycophenolic Acid Treatment Not Associated with More Severe COVID-19 Infection
September 28th 2022Throughout the pandemic, rheumatologists have been concerned that their patients may be at risk of developing more severe forms of the COVID-19 disease as a result of their rheumatic disease or treatment.
Read More
Fatigue May Artificially Increase Disease Activity Scores in Lupus
September 21st 2022Fatigue, a highly multifactorial manifestation of lupus, can be related to disease activity or independent of the disease itself. Investigators determined whether fatigue could be a significant confounder of Physician Global Assessment ratings.
Read More
Yoga Program Improves Physical Function in Patients with Knee Osteoarthritis
September 21st 2022"Online interventions have the potential to reach a wide audience, allowing exercise to be undertaken from the comfort and convenience of home and thereby overcoming some of the barriers to exercise reported in the osteoarthritis population.”
Read More
American College of Rheumatology Releases 2022 Rheumatic Disease Report Card
September 20th 2022Rebecca Shepherd, MD, MBA, FACR, FACP, discusses the American College of Rheumatology's 2022 Rheumatic Disease Report Card in depth, including what can be done to improve scores and the next steps for her team.
Read More
Rheumatology Research Foundation to Award Grant to Clinical Practice Rheumatologist
September 19th 2022The Rheumatology Research Foundation has recently announced a grant, called the Community Practice Innovation Award, which focuses on supporting rheumatology practitioners to conduct their crucial, and potentially life-changing, research.
Read More
Q&A: ACR’s Updated Guidelines for Prevention, Treatment of Glucocorticoid-Induced Osteoporosis
September 16th 2022The guidelines will provide more options for the treatment and prevention of glucocorticoid-induced osteoporosis and will inform rheumatologists about the requirements for anti-resorptive therapy after anabolic agents are discontinued.
Read More
Pegloticase Injection Plus Methotrexate Significantly Increases Response Rate in Patients with Gout
September 15th 2022Results were based on the phase 4 MIRROR trial, which analyzed differences in treatment response for concomitant therapy compared with placebo in adults with uncontrolled gout.
Read More
Patients with Autoimmune Disease at Greater Complications Risk Following Heart Attack
September 14th 2022Investigators believe that coronary intervention, intensified medical therapy, and an aggressive risk factor optimization approach should be available to patients with rheumatic disease presenting with myocardial infarction whenever possible.
Read More
Litifilimab Superior to Placebo in Patients with Cutaneous Lupus Erythematosus
September 8th 2022“Whether treatment with litifilimab, a humanized monoclonal antibody against BDCA2, would be efficacious in reducing disease activity in patients with cutaneous lupus erythematosus has not been extensively studied.”
Read More